CN Patent
CN105461713A — 苯并萘啶类的新化合物及其组合物和用途
Assigned to Individual · Expires 2016-04-06 · 10y expired
What this patent protects
本发明的苯并萘啶类化合物具有较少的吸湿性、较好的存储稳定性,该化合物适用于制备用于人或动物的因脑型、凶险型及耐氯喹虫株所致的恶性疟、间日疟、矽肺、逆转肿瘤多药耐药性、乙型肝炎、抗窦性心律失常等疾病的治疗或预防的药物中的应用。
USPTO Abstract
本发明的苯并萘啶类化合物具有较少的吸湿性、较好的存储稳定性,该化合物适用于制备用于人或动物的因脑型、凶险型及耐氯喹虫株所致的恶性疟、间日疟、矽肺、逆转肿瘤多药耐药性、乙型肝炎、抗窦性心律失常等疾病的治疗或预防的药物中的应用。
Drugs covered by this patent
- Livtencity (MARIBAVIR) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.